The federal authorities, Thursday reaffirmed its dedication to advertise native manufacturing of prescription drugs by way of coverage enablement, funding mobilisation, regulatory enchancment, tax reliefs, native analysis facilitation and ease of doing enterprise.
Minister of State for Well being and Social Welfare, Dr Iziaq Adekunle Salako, acknowledged this whereas delivering his speech on the grand opening of Sam Pharmaceutical LTD OTA Plant at Ilo-Awela Street, Ota, Ogun state.
He acknowledged the significance of the occasion can’t be over-emphasized, particularly at a time of renewed dedication to unlock healthcare worth chain, not only for {economic} causes however as a key enabler of medical sovereignty.
Dr Salako added that the management of President Bola Ahmed Tinubu has now positioned the sector to drive progress and growth in lots of different ancillary sectors.
The minister acknowledged additional that the federal government has developed daring initiatives to drive reforms within the pharmaceutical manufacturing area, together with Presidential Initiative to Unlock Healthcare Worth Chains (PVAC), the Presidential Govt Order for Pharmaceutical and Allied Sectors, focused at revitalising native manufacturing as a driving pressure for Nigeria’s Well being Sector reforms.
Dr Salako acknowledged that the Manufacturing and Entry to Vaccines, Medicines and Well being Applied sciences (MAV+) venture, Africa’s most bold vaccines’ analysis, growth and native manufacturing initiative to the tune of 18 million Euro have been signed, and launched since October 2025 and it’s anticipated to learn with particular capability strengthening for stakeholders together with native producers with a purpose to enhance entry to healthcare by way of the native production of key inputs together with vaccines, biologics, diagnostics and units.